14th Summit on Biosimilars & Innovator Biologics
Event summary
The 14th Summit on Biosimilars & Innovator Biologics discussed hot industry topics, including the rules governing significant matters like interchangeability, substitution and equivalency. Speakers included representatives from government agencies, industry leaders and seasoned counsel discussing legal, regulatory and commercial strategies for the innovator and biosimilars marketplace.
Featured agenda item
Wednesday, June 28, 2023 | 11:30 am – 12:30 pm EDT
Breaking Into the Biologics and Biosimilars Market: Devising Forward-Thinking Portfolio Strategies
Cooley partner Eamonn Gardner spoke on this panel.
For more information, please email Megan Senerchia.
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.